1. Toward a mathematical modeling of diseases’ impact on bone remodeling: technical review;Ait Oumghar;Front Bioeng Biotechnol,2020
2. Pathogenesis of myeloma bone disease;Roodman;Blood Cells Mol Dis,2004
3. Metabolism and toxicological implications of commonly used chemopreventive drugs against breast cancer/carcinogenesis;Muhammad;Curr Drug Metab,2017
4. High prevalence of vertebral fractures in women with breast cancer starting aromatase inhibitor therapy;Bouvard;Ann Oncol,2012
5. P. Barry, T. Aspray, K. Briers, and others, “Osteoporosis: assessing the risk of fragility fracture (NICE Clinical Guidance 146,” National Institute for Health and Care Excellence, 2012.